A risk-based postresection follow-up strategy for hepatocellular carcinoma patients

Yizhen Fu1,2, Xia Li3, Zhenyun Yang1,2

  • 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.

Cancer
|December 21, 2022
PubMed
Abstract

Related Concept Videos